Analyst Ratings for Monopar Therapeutics (MNPR)

MNPR Rating Summary

MNPR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MNPR
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $110.75 (+92.2%) * Over Last 12-Mos
Rating Score: 9.4 / 10   Percentile Rank: 91%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/9/2026 Morgan Stanley Maxwell Skor New Coverage Overweight
(N/A)		 115.00
(N/A)		 65.01
(57.61)		 -11.38% Details
11/14/2025 Raymond James
» Updated 1/7/2026		 Chris Raymond Downgrade Outperform
(Strong Buy)		 123.00
(N/A)		 87.01
(57.61)		 -33.79% Details